| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Mirum Pharmaceuticals, Inc. (MIRM) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. MIRM is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 205.1K | $21.97M | -30,000 | |
| COO | 40.3K | $4.31M | - | |
| CFO | 26.7K | $2.86M | -5,000 | |
| Other | 18.9K | $2.02M | - | |
| VP | 5.8K | $625.1K | -2,594 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Quan Joanne | Chief Medical Officer | Sale+OE | 7,287 | $91.98 | $670,242.96 | -27.9% | +7.2% | - | |
| Feb 13, 2026 | Ramasastry Saira54 | Director | Sale+OE | 2,000 | $102.09 | $204,180.00 | -100% | +8.0% | - | |
| Feb 2, 2026 | Peetz Christopher45 | Chief Executive Officer | Sell | 9,108 | $103.30 | $940,888.28 | -5.4% | -7.0% | - | |
| Feb 2, 2026 | Radovich Peter | President And COO | Sell | 2,631 | $103.30 | $271,791.51 | -11.3% | -7.0% | - | |
| Feb 2, 2026 | Howe Jolanda | SVP, Global Controller | Sale+OE | 968 | $103.30 | $99,997.79 | -17.7% | -7.0% | - | |
| Jan 15, 2026 | Ramasastry Saira54 | Director | Sale+OE | 2,000 | $90.99 | $181,980.00 | -100% | +3.1% | - | |
| Dec 22, 2025 | Ramasastry Saira54 | Director | Sale+OE | 5,000 | $80.00 | $400,000.00 | -100% | +10.3% | - | |
| Dec 19, 2025 | Grey Michael G49 | Director | Sale+OE | 50,000 | $78.00 | $3,900,000.00 | -100% | +16.7% | - | |
| Dec 18, 2025 | Ramasastry Saira54 | Director | Sale+OE | 2,000 | $69.73 | $139,460.00 | -66.7% | +30.4% | - | |
| Dec 1, 2025 | Grey Michael G49 | Director | Sale+OE | 50,000 | $74.00 | $3,700,000.00 | -100% | +28.7% | - |